Evidence map›Paper›PMID 36501205›Full record

SynthesisNutrients2022

Health Effects of Infant Formula Supplemented with Probiotics or Synbiotics in Infants and Toddlers: Systematic Review with Network Meta-Analysis.

Flavia Indrio, Pedro Gutierrez Castrellon, Yvan Vandenplas, Ener Cagri Dinleyici, Ruggiero Francavilla, Massimo Pettoello Mantovani, Assunta Grillo, Isadora Beghetti, Luigi Corvaglia, Arianna Aceti

Abstract readSystematic ReviewNetwork Meta-Analysis
In one paragraph

Synthesis in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Acute Infectious Diarrhea.Advances in experimental medicine and biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Flavia IndrioDepartment of Medical and Surgical Science Pediatric Section, University of Foggia, 71100 Foggia, Italy.
Pedro Gutierrez CastrellonCentro de Investigación Translacional en Ciencias de la Salud, Hospital General Dr. Manuel Gea González, 14080 Ciudad de México, Mexico.
Yvan VandenplasUZ Brussel, KidZ Health Castle, Vrije Universiteit Brussel, 1090 Brussels, Belgium.ORCID 0000-0002-1862-8651
Ener Cagri DinleyiciDepartment of Pediatrics, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26480, Turkey.ORCID 0000-0002-0339-0134
Ruggiero FrancavillaInterdisciplinary Department of Medicine, Pediatric Section, Children's Hospital 'Giovanni XXIII', University of Bari Aldo Moro, 70126 Bari, Italy.ORCID 0000-0002-4603-974X
Massimo Pettoello MantovaniDepartment of Medical and Surgical Science Pediatric Section, University of Foggia, 71100 Foggia, Italy.
Assunta GrilloDepartment of Medical and Surgical Science Pediatric Section, University of Foggia, 71100 Foggia, Italy.
Isadora BeghettiDepartment of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.ORCID 0000-0003-4819-1830
Luigi CorvagliaDepartment of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
Arianna AcetiDepartment of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.ORCID 0000-0001-9274-985X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Supplementation of infant and follow-up formula with probiotics or synbiotics has become a common practice. In 2011 and 2017, the evidence regarding the impact of these interventions was analysed systematically. Recently new evidence was published. To evaluate through a systematic review with network meta-analysis the evidence on the impact of infant formula supplemented with probiotics or synbiotics for healthy infants and 36-month-old toddlers. RCTs published between 1999-2019 for infant formulas supplemented with probiotics alone or synbiotics in healthy infants and toddlers were identified. Data analysis included clinical (gastrointestinal symptoms, risk reduction of infectious diseases, use of antibiotics, weight/height gain and frequency of adverse events) and non-clinical outcomes (changes in faecal microbiota and immune parameters). A random effect model was used. Hedges' standard mean difference (SMD) and risk ratio (RR) were calculated. Rank analysis was performed to evaluate the superiority of each intervention. Twenty-six randomised controlled trials with 35 direct comparisons involving 1957 children receiving probiotic-supplemented formula and 1898 receiving control formula were reviewed. The mean duration of intervention was 5.6 ± 2.84 months. Certain strains demonstrated a reduction in episodes of colic, number of days with fever and use of antibiotics; however, there was considerable heterogeneity which reduced the level of certainty of effect. No significant effects were observed on weight, height or changes in faecal proportions of

Indexed as

ProbioticsSynbioticsAnti-Bacterial AgentsBifidobacteriumChild, PreschoolHumansInfantInfant FormulaWeight GainAnti-Bacterial Agentsinfant formulainfants and toddlerssupplemented probioticssynbiotics

Identifiers

PMID36501205
PMCPMC9739048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.